A77 1726 ≥98% (by HPLC)

Supplier: Enzo Life Sciences

Synonyms: 2-Cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)but-2-enamide, (E/Z)-Teriflunomide

430-096-M005 430-096-M025
89151-098EA 116.92 CAD
89151-098 89151-100
A77 1726 ≥98% (by HPLC)
A77 1726

Dihydrorotate dehydrogenase inhibitor


Physiologically active metabolite of the immunosuppressive drug leflunomide (Prod. No. ALX-430-095). Inhibits the activity of dihydrorotate dehydrogenase and of protein tyrosine kinases. Blocks TNF-mediated NF-kappaB activation in a dose- and time-dependent manner. Also inhibits the activity of cyclooxygenase-2 (COX-2) in vitro and in vivo.

Formula: C₁₂H₉F₃N₂O₂
MW: 270.211 g/mol
MDL Number: MFCD00910058
CAS Number: 108605-62-5
https://digitalassets.avantorsciences.com/adaptivemedia/rendition?id=b4971d30e619fc40638bc5f5e82ba3047673a59f&vid=c56038f188faa47917da83574ce0278fd69d0f09&prid=web&clid=SAPDAM

Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR